CompletedNot Applicable

Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

United States69 participantsStarted 2023-07-05

Plain-language summary

An observational, retrospective, cross-sectional, multicenter study. Real-world data were obtained from medical records of Spanish public hospitals (9 hospitals).

Who can participate

Age range14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patients diagnosed with SMA type I or SMA type II. * Patients with medical records available in the hospital. * Patients diagnosed with SMA type I or SMA type II after 2017 for whom a minimum of 6 months of follow-up was available. Exclusion criteria: • Patients who participated in an experimental design study except for those in the long-term follow-up period, during the observation period.

What they're measuring

Cost per Year of Use of Resources for Medical Visits

Timeframe: Up to 12 months

Costs per Year of Use of Resources for Medical Tests

Timeframe: Up to 12 months

Cost per Year of Use of Resources for Treatment

Timeframe: Up to 12 months

Trial details

NCT IDNCT06632730

SponsorNovartis

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-11-20

View on ClinicalTrials.gov More Spinal Muscular Atrophy Type I trials